Global Depression Therapy & Treatment Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 – 2023

Global Depression Therapy & Treatment Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 – 2023

  • February 2016 •
  • 140 pages •
  • Report ID: 4366024
Depression treatment market is segmented on the basis of antidepressants drugs, devices and therapies. Antidepressants are the largest market segment.

Antidepressants are the most popular treatment methods. Every year more than five billion prescriptions are written globally. Antidepressants segment consists of big pharmaceuticals companies like Eli Lily, Pfizer, GlaxoSmithKline and Forest Laboratories. All these companies are branded drug manufacturers.

Some of the popular drugs produced by these companies are Cymbalta (Eli Lily) and Effexor and Pristiq (Pfizer). The devices market is the fastest growing market segment.

1. Pfizer
2. GlaxoSmithKline
3. Forest Laboratories
4. Abbot Laboratories
5. Eli Lilly and Company
6. Merck Sharp &Dohme
7. Sanofi
8. Teva Pharmaceuticals Industries
9. Mayo Clinic
10. Sun Pharmaceuticals
11. Brainsway
12. Fisher Wallace
13. MagVentures
14. Lundbeck
15. BoehringerIngelheim GmbH
16. Roche Holding AG


This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies